Evidence map›Paper›PMID 41689021›Full record

ArticleSubstance abuse treatment, prevention, and policy2026

The power of people who use drugs as mass media influencers in changing public opinion during the global overdose epidemic.

Ehsan Jozaghi, Vancouver Area Network of Drug Users (Vancouver Area Network of Drug Users is a consortium/not-for-profit)

Abstract read
In one paragraph

Article in Substance abuse treatment, prevention, and policy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Ehsan JozaghiThe University of British Columbia, Vancouver, BC, V6T 1Z3, Canada. ejozaghi02@gmail.com.
Vancouver Area Network of Drug Users (Vancouver Area Network of Drug Users is a consortium/not-for-profit)

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThousands of people have lost their lives due to overdose-related fatalities linked to the potent synthetic opioid epidemic, as mortalities increase annually. British Columbia (B.C.) Canada has been an exception, where the population not only has more liberal views on illegal drugs, but overdose death numbers have reduced for the first time in recent months. The reduction of overdose deaths in BC and liberal views have taken place in conjunction with the Vancouver Area Network of Drug Users’ (VANDU) advocacy growth over the past two decades.

methodsThe Canadian Newsstream database, which contains news media coverage, was utilized to examine VANDU’s news coverage and impact in 2023. VANDU’s mass media impact is determined qualitatively. NVivo 14 facilitated coding 97 articles in 2023, out of 1,596 total news articles since 1997.

resultsAfter analyzing 97 articles from 42 blogs, 33 newspapers, 21 wire feeds, and one other source, five themes were identified. These themes included (1) policy engagement, (2) Government lobbying, (3) Advocacy, (4) Unsanctioned work, and (5) Demonstration.

conclusionWith the rise of pseudoscience and anti-harm reduction rhetoric across the globe, this research has shown that partnering and funding drug user advocacy groups is the most critical way to fight the overdose epidemic because the advocacy can change public opinion and therefore government policy that needlessly contributes to preventable deaths.

Indexed as

Drug OverdoseDrug UsersMass MediaPower, PsychologicalPublic OpinionBritish ColumbiaEpidemicsHumansLobbyingMedia ExposureActivismAddictionAdvocacyHarm reductionMass mediaPeople who use drugsSocial mediaVANDU

Identifiers

PMID41689021
PMCPMC12983675

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.